Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

BACKGROUND: A barrier to the successful development of new disease treatments is the timely recruitment of participants to experimental medicine studies that are primarily designed to investigate biological mechanisms rather than evaluate clinical efficacy. The aim of this study was to analyse the p...

Descripció completa

Dades bibliogràfiques

Publicat a:	Trials
Autors principals:	Heywood, James, Evangelou, Marina, Goymer, Donna, Kennet, Jane, Anselmiova, Katerina, Guy, Catherine, O’Brien, Criona, Nutland, Sarah, Brown, Judy, Walker, Neil M, Todd, John A, Waldron-Lynch, Frank
Format:	Artigo
Idioma:	Inglês
Publicat:	BioMed Central 2015
Matèries:	Research
Accés en línia:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4369347/ https://ncbi.nlm.nih.gov/pubmed/25881192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0583-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!